[AIDS and human immunodeficiency virus infection in Africa]. 1988

P Piot, and R Colebunders, and M Laga, and B Standaert, and H Taelman, and G Van der Groen

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D008297 Male Males
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009894 Opportunistic Infections An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. Infection, Opportunistic,Infections, Opportunistic,Opportunistic Infection
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III

Related Publications

P Piot, and R Colebunders, and M Laga, and B Standaert, and H Taelman, and G Van der Groen
January 1986, Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg,
P Piot, and R Colebunders, and M Laga, and B Standaert, and H Taelman, and G Van der Groen
May 1987, The New England journal of medicine,
P Piot, and R Colebunders, and M Laga, and B Standaert, and H Taelman, and G Van der Groen
January 1996, East African medical journal,
P Piot, and R Colebunders, and M Laga, and B Standaert, and H Taelman, and G Van der Groen
May 1999, Clinical and diagnostic laboratory immunology,
P Piot, and R Colebunders, and M Laga, and B Standaert, and H Taelman, and G Van der Groen
February 1998, Revue d'epidemiologie et de sante publique,
P Piot, and R Colebunders, and M Laga, and B Standaert, and H Taelman, and G Van der Groen
August 1987, Canadian family physician Medecin de famille canadien,
P Piot, and R Colebunders, and M Laga, and B Standaert, and H Taelman, and G Van der Groen
September 1991, Journal of thoracic imaging,
P Piot, and R Colebunders, and M Laga, and B Standaert, and H Taelman, and G Van der Groen
June 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
P Piot, and R Colebunders, and M Laga, and B Standaert, and H Taelman, and G Van der Groen
October 1990, Vnitrni lekarstvi,
P Piot, and R Colebunders, and M Laga, and B Standaert, and H Taelman, and G Van der Groen
June 2008, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,
Copied contents to your clipboard!